Loss-of-function mutations in PTCH1 underlie the molecular cause of Gorlin syndrome (also known as nevoid basal cell carcinoma syndrome), a rare condition characterised by an increased risk of developing various tumours, commonly medulloblastoma, rhabdomyosarcoma and basal cell carcinoma [58]. Here, PTCH1 is linked to basal cell carcinoma.